FDA Investigator Anthony J Ladner

Anthony J Ladner has inspections in 3 countries as of 17 Oct 2023. Anthony J Ladner has collaborated with a combinined 2670 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
54
Last Inspection Date:
17 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
100000210
Country:
United States of America, Canada, India
Co-Investigator(s):
Abby E Pelletier, Aimee J Edwin, Alan M Barker, Alecia L Marson, Alicia M Mozzachio, Allen F Hall, Amy L Mcintyre, Ana M Placencia, Anders W Evenson, April L Brown, April L Young, Arsen Karapetyan, Azza Talaat, Baask, Barbara M Frazier, Bei Y He, Benedict, Benjamin W Anderson, Bonita S Chester, Bradley A Servais, Brenda W Uratani, PhD, Brett R Havranek, Bryan L Mcguckin, Carolyn A Warren, Charles L Zhou, Charles M Edwards, Charles R Cote, RIC, Cheryl A Clausen, Christopher D Leach, Como, Concepcion Cruz, Jr, Courtney R Ingalsbe, Courtney R Tiegs, Dacia E Quick, Dale A Nyberg, Danial S Hutchison, Daniel J Roberts, Daniel L Aisen, David A Oluwo, David B Wieneke, Denise L Burosh, Denise M Digiulio, Dennis Cantellops Paite, Dipesh K Shah, Edward M James, Emilie E Kahn, Emily E Markgraf, Eric M Mueller, PharmD, Eric S Myskowski, Erika V Butler, Fannie M Harrell, Felix Maldonado, Grant M Ruis, Gregory A Berg, Gregory W Smith, Guo Q Shen, Gwyn G Dickinson, Howard A Burmester, Ivan E Reyes, Ivis Lnegron Torres, Jacob W Reynolds, James K Ireland, Janis R Armedoriz, Jasjeet K Sekhon, Jeanne D Shaffer, Jeanne M Morris, Jeffry A Bernhardt, Jennifer Al Vollon, Jennifer Alongie Vollom, Jennifer S Ness, Joel D Hustedt, Joel D Martinez, John E Emmert, Jonathan G Gayechuway, Jonathan G Swoboda, Jonathan L Blonk, Jose Alopez Rubet, Joseph A Piechocki, Joseph R Lambert, Justin A Boyd, Kellie L Thommes, RN, Kellie L Westerbuhr, Kenneth A Libertoski, Kenneth H Williams, Kevin P Regan, Krista K Petersen, Kristy E Zuroski, Ladner Ladner, Anthony J, Lauren E Sanger, Lequita M Mayhew, Linda V Weyer, Lisa L Flores, Lisa M Lopez, Logan T Williams, Lucas B Leake, M Edith Snyder, Maf Maf, Margaret L Bolte, Marie A Fadden, Marissa S Henning, Marissa S Steinhagen, Matthew B Casale, Meisha R Sampson, Meisha Waters, Melissa I Michurski, Michael A Taylor, Michael E Cimaglio, Michele Perry Williams, Minerva Rogers, Monica E Murie, Muralidhara B Gavini, PhD, Nadine J Nanko, Nathan B Davis, Nicole C Victoria, PhD, Nicole E Knowlton, Norman K Starks, Pankaj H Amin, Patrick B Cummings, Peter T Erlandson, Pratik S Upadhyay, DDC, Rafeeq A Habeeb, Ralph Jerndal, Rebecca L Caulfield, Robert J Martin, Ross J Grigsby, Sandra A Hughes, Sandra D Wilson, Sandra D Wilson Newby, Sandra Sejdinovic, Scott A Golladay, Scott B Laufenberg, Sean R Marcsisin, Sharon K Thoma, PharmD, Sharon L Matson, Soyinka S Eneng, Srenda W Uratani, State Agency, Susan M Matthias, Tamara J Umscheid, Tenzin Jangchup, Terrance L Scheiber, Timothy R Marrs, Ucheabuchi C Chudi Nwankwor, Victoria A Wagoner, Warren J Lopicka, William A Warnick, William E Keer, William J Leonard, Yiyue Zhang (nmi), PhD

Anthony J Ladner's Documents

Publish Date Document Type Title
January, 2020 FDA 483 Quality Blending, Inc - Form 483, 2020-01-30
June, 2016 EIR Sterling Wisconsin, LLC - EIR, 2016-06-24
June, 2019 FDA 483 Northland Nuclear Medicine, LLC - Form 483, 2019-06-07
April, 2018 FDA 483 Response Fairview Compounding Phamacy - Form 483R, 2018-06-26
February, 2020 EIR Unichem Laboratories Limited - EIR, 2020-02-21
April, 2019 EIR Fagron Inc - EIR, 2019-04-10
June, 2016 FDA 483 W & C dba The Apothecary - Form 483, 2016-06-17
December, 2016 FDA 483 ProMed Pharma, LLC - Form 483, 2016-12-08
September, 2018 FDA 483 Thrifty White Drug #762 - Form 483, 2018-09-21
July, 2018 FDA 483 Padagis US LLC - Form 483, 2018-07-31
February, 2017 FDA 483 Federal Package Network, Inc. - Form 483, 2017-02-17
March, 2022 FDA 483 Fagron Compounding Services - Form 483, 2022-03-24
August, 2021 FDA 483 IntegraDose Compounding Services LLC - Form 483, 2021-08-02
September, 2019 FDA 483 Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy - Form 483, 2019-09-27
March, 2022 EIR Fagron Compounding Services - EIR, 2022-04-22
March, 2017 FDA 483 LTS Therapy Systems, LLC - Form 483, 2017-03-29
November, 2016 FDA 483 Scribe Manufacturing Inc - Form 483, 2016-11-17
April, 2019 FDA 483 Fagron Inc - Form 483, 2019-04-10
February, 2017 FDA 483 Celletech, Ltd - Form 483, 2017-02-03
June, 2018 FDA 483 WINDLAS BIOTECH LIMITED - Form 483, 2018-06-01
December, 2017 FDA 483 Fagron Inc - Form 483, 2017-12-21
December, 2019 EIR Noble Pharma, LLC - EIR, 2019-12-18
January, 2019 FDA 483 Kindeva Drug Delivery L.P. - Form 483, 2019-01-25
July, 2017 FDA 483 Heartland I.V. Care - Form 483, 2017-07-14
April, 2018 FDA 483 Fairview Compounding Phamacy - Form 483, 2018-04-18
December, 2017 FDA 483 Response Fagron Inc - Form 483R, 2018-01-12

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more